There are two kinds of videos for your viewing: short educational topics called Clinical Minutes (2-4 minutes long) and longer educational segments labeled Videos.
Physicians at John Muir Health were among the first in Northern California to offer patients new minimally invasive treatment options including transcatheter aortic valve replacement (TAVR) to treat aortic stenosis and MitraClip for patients suffering from mitral regurgitation (MR).
Gary Gershony, MD, discusses currently available catheter therapies in the treatment of Structural Heart Disease (SHD).
This video presentation provides a framework on how to approach evaluating mitral regurgitation: anatomy, diagnosis, and pathophysiology.
The John Muir Health Transcatheter Aortic Valve Replacement (TAVR) Team provide a joint presentation on the prevalence of Aortic Stenosis (AS) and the use of TAVR as a treatment for appropriate candidates.
Repair retains the heart’s natural shape and function better than replacement. Patients who undergo valve replacement must take blood thinners for the rest of their lives.
Aortic stenosis (AS) is a narrowing of the aortic valve, often caused by a build-up of calcium on the aortic valve leaflets.